Cargando…

Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer

OBJECTIVE: Epidemiologic studies have linked smoking to various malignancies, including bladder cancer, but its underlying biological functions remain elusive. Currently, we aimed to identify the smoking-related epigenetic modifications and disclose their impacts on prognosis and therapies in bladde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Ya, Li, Jindong, Zhou, Lijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074629/ https://www.ncbi.nlm.nih.gov/pubmed/37011378 http://dx.doi.org/10.1177/03946320231166774

Ejemplares similares

An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
por: Hou, Jian, et al.
Publicado: (2022)

The chemotherapeutic drug carboplatin affects macrophage responses to LPS and LPS tolerance via epigenetic modifications
por: Boonmee, Atsadang, et al.
Publicado: (2021)

Association of smoking status with prognosis in bladder cancer: A meta-analysis
por: Hou, Lina, et al.
Publicado: (2016)

Genetic and epigenetic modifications induced by chemotherapeutic drugs: human amniotic fluid stem cells as an in-vitro model
por: Upadhyaya, Prabin, et al.
Publicado: (2019)

Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Lu, Maoqing, et al.
Publicado: (2021)

Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer
por: Yang, Xihua, et al.
Publicado: (2018)

Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
por: Wang, Zewei, et al.
Publicado: (2020)

FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma
por: Li, Mao-Ran, et al.
Publicado: (2017)

Identification of autophagy‐related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2021)

Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression
por: Chen, Jue, et al.
Publicado: (2015)

Utility of SAM68 in the progression and prognosis for bladder cancer
por: Zhang, Zhiling, et al.
Publicado: (2015)

A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
por: Harsanyi, Stefan, et al.
Publicado: (2022)

Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer
por: Zhang, Liqun, et al.
Publicado: (2019)

Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment
por: Kloskowski, T., et al.
Publicado: (2021)

Smoking Behaviors and Prognosis in Patients With Non–Muscle-Invasive Bladder Cancer in the Be-Well Study
por: Kwan, Marilyn L., et al.
Publicado: (2022)

Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcriptome analysis
por: Yu, Xiao, et al.
Publicado: (2023)

Determination of Genetic and Epigenetic Modifications-Related Prognostic Biomarkers of Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
por: Goldman, Samantha L., et al.
Publicado: (2019)

Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines
por: Vural, Suleyman, et al.
Publicado: (2021)

Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer
por: Zhang, Peng, et al.
Publicado: (2023)

Epigenetic modifications of histones in cancer
por: Zhao, Zibo, et al.
Publicado: (2019)

Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
por: Wang, Jie, et al.
Publicado: (2018)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
por: Lindsay, Cameron, et al.
Publicado: (2017)

Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
por: Li, Jingjing, et al.
Publicado: (2017)

Somatic mutations in colorectal cancer are associated with the epigenetic modifications
por: Lei, Hongwei, et al.
Publicado: (2020)

Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivo
por: WANG, DEGUI, et al.
Publicado: (2013)

Epigenetic Modifications Related to Potato Skin Russeting
por: Kumar, Pawan, et al.
Publicado: (2023)

Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Smoking and Bladder Cancer in Egypt
por: Makhyoun, N. A.
Publicado: (1974)

Modification of Interleukin-15 Serum Levels in Workers Exposed to Chemotherapeutic Agents
por: Spatari, Giovanna, et al.
Publicado: (2005)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Genetic and Epigenetic Alterations in Bladder Cancer
por: Li, Hong-Tao, et al.
Publicado: (2016)

Epigenetic and Immunological Features of Bladder Cancer
por: Gilyazova, Irina, et al.
Publicado: (2023)

Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence
por: Xiao, Wei, et al.
Publicado: (2014)

Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer
por: Chen, Xingyu, et al.
Publicado: (2020)

Epigenetic Modifications in Head and Neck Cancer
por: Gaździcka, Jadwiga, et al.
Publicado: (2019)

A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer
por: Sun, Liang, et al.
Publicado: (2015)

Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer
por: Mansour, Ahmed M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k10dnn5slg152ismjsacm3ovdu